Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | EVP&Pres, LLY USA&Global Capab | June 10, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date June 10, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 29,804.111 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Sale · Disposed 2,500 · Balance 29,804.111 F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 11, 2026 20:23 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 2,500 | $1,150.77 | $2,876,925.00 |
DisclosureSEC source: 0001826001-26-000006 · wk-form4_1781209410.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,804.111 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2026. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:26 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,162.504 | $1,044.67 | $4,348,443.05 |
DisclosureSEC source: 0001826001-26-000004 · wk-form4_1770845161.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,304.111 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001826001-26-000002 · wk-form4_1770154355.xml · derivative · entry 3 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,394 shares Expires 2026-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,512.364 | $1,037.15 | $1,568,548.32 |
DisclosureSEC source: 0001826001-26-000002 · wk-form4_1770154355.xml · nonDerivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,141.607 Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:32 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,394 | $0.00 | $0.00 |
DisclosureSEC source: 0001826001-26-000002 · wk-form4_1770154355.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,653.971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2025 Filed Aug 12, 2025 20:16 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,250 | $627.01 | $783,762.50 |
DisclosureSEC source: 0000059478-25-000208 · wk-form4_1755029810.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP&Pres, LLY USA&Global Capab 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,259.971 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2025. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:17 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,250 | $749.24 | $936,550.00 |
DisclosureSEC source: 0000059478-25-000144 · wk-form4_1747340244.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,509.971 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2025. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:30 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 3,394 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000061 · wk-form4_1739395815.xml · derivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,394 Underlying: Common Stock · 3,394 shares Expires 2026-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:30 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 7,123.348 | $868.88 | $6,189,334.61 |
DisclosureSEC source: 0000059478-25-000061 · wk-form4_1739395815.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,759.971 Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000034 · wk-form4_1738704486.xml · derivative · entry 3 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,269 shares Expires 2025-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,434.377 | $811.08 | $1,163,394.50 |
DisclosureSEC source: 0000059478-25-000034 · wk-form4_1738704486.xml · nonDerivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,636.623 Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:28 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-25-000034 · wk-form4_1738704486.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 3,269 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000046 · wk-form4_1707946126.xml · derivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,269 Underlying: Common Stock · 3,269 shares Expires 2025-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,790 | $737.26 | $3,531,475.40 |
DisclosureSEC source: 0000059478-24-000046 · wk-form4_1707946126.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,802 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionRestricted Stock Unit · Derivative | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000025 · wk-form4_1706909331.xml · derivative · entry 3 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,702 shares Expires 2024-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | Tax withholdingCommon Stock | 1,664 | $645.61 | $1,074,295.04 |
DisclosureSEC source: 0000059478-24-000025 · wk-form4_1706909331.xml · nonDerivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,012 Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:29 UTC | ELI LILLY & Co LLY · Entity 2794 | Exercise / conversionCommon Stock | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-24-000025 · wk-form4_1706909331.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:19 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantRestricted Stock Unit · Derivative | 3,702 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-23-000071 · wf-form4_167641314104117.xml · derivative · entry 2 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,702 Underlying: Common Stock · 3,702 shares Expires 2024-02-01 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:19 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 1,350 | $345.12 | $465,912.00 |
DisclosureSEC source: 0000059478-23-000071 · wf-form4_167641314104117.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · EVP & President, LLY Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,974 Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $242.58 | $242,580.00 |
DisclosureSEC source: 0000059478-22-000063 · wf-form4_164513402373017.xml · nonDerivative · entry 2 Yuffa Ilya · CIK 0001826001 · SVP & President, LLY Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,624 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2021. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:40 UTC | ELI LILLY & Co LLY · Entity 2794 | SaleCommon Stock | 1,000 | $237.45 | $237,450.00 |
DisclosureSEC source: 0000059478-22-000063 · wf-form4_164513402373017.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · SVP & President, LLY Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,624 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2021. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 23:42 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,275 | $243.27 | $796,709.25 |
DisclosureSEC source: 0000059478-22-000058 · wf-form4_164462288785243.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · SVP & President, LLY Int'l 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,624 Read SEC document |
| February 08, 2021 Filed Feb 11, 2021 01:50 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 3,536 | $205.77 | $727,602.72 |
DisclosureSEC source: 0000059478-21-000068 · wf-form4_161300819720563.xml · nonDerivative · entry 1 Yuffa Ilya · CIK 0001826001 · SVP and Pres, Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,349 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.